Public consultations enable the HPRA to identify the needs and expectations of stakeholders so that we may incorporate their views into the way our services are planned and delivered.
- The European Commission has launched a stakeholder consultation on the EU legislation on blood, tissues and cells. Further details on this consultation details are available on our Regulatory News section
- The HPRA has recently undertaken a public consultation on Medical Devices Distributor Guidance. The consultation period has now ended. A response document on the outcome of the consultation will be published in due course.
All response document will provide a general overview of the comments received and the changes made to the proposals as a result.
Consultations comply with government policy, as described in the document ‘Reaching out: Guidelines on Consultation for Public Sector Bodies’.
Outcomes from previous Consultations process
Public Consultation on proposed Human and Veterinary Medicines, Medical Devices, and Compliance Fees for 2017 - Outcome of the Process
For further information and a list of previous consultations please see previous consultations page.